- SEK12.88bn
- SEK12.36bn
- SEK1.54bn
Brief: Biogaia's Oral Health Probiotic Reduces Bleeding Of Gums
Brief: Biogaia Q4 Operating Profit Falls SEK 68.1 Million
Brief: Biogaia Signs Exclusive Agreement In Tunisia
Brief: BioGaia Appoints Alexander Kotsinas As New CFO
Brief: Biogaia Q3 Operating Profit Down At SEK 49.5 Million
Brief: Biogaia’s Probiotic Effective As Adjunct In Patients With Helicobacter Pylori Infection
Brief: Biogaia Says Estimates Delays To Affect Sales To Distribution Partners, Earnings In Both Q3 & Q4
Brief: Biogaia Q2 Operating Profit At SEK 78.5 Million
Brief: Biogaia Signs Exclusive Agreement In Uruguay
Swedish stocks: Seen opening near flat, SKF rival Schaeffler confirms outlook
Brief: Biogaia Q1 Operating Profit Falls To SEK 46.4 Million
Brief: Biogaia's Probiotic Decreases Pain In Patients With Diverticulitis
Swedish stocks: Seen opening flat
Brief: Biogaia Q4 Operating Profit Up At SEK 75.1 Million
Swedish stocks: Seen opening higher, Nordea Q3 profit lags expectations
Brief: Biogaia Q3 Op Profit Rises 23 Pct In Q3
Swedish stocks: Seen opening lower, Peab Q2 order intake up 26 pct
Brief: Biogaia Q2 Adjusted Operating Profit rises 19 pct
Brief: Biogaia Invests Further In Metabogen